# GLucose Monitoring Programme SingaporE, Phase 2 (GLiMPSE2)

> **NCT04564911** · NA · UNKNOWN · sponsor: **Singapore General Hospital** · enrollment: 206 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Flash Glucose Monitoring

## Interventions

- **COMBINATION_PRODUCT:** Flash Glucose Monitoring and Education
- **COMBINATION_PRODUCT:** Capillary glucose monitoring and Education

## Key facts

- **NCT ID:** NCT04564911
- **Lead sponsor:** Singapore General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12-22
- **Primary completion:** 2023-09-30
- **Final completion:** 2023-12-30
- **Target enrollment:** 206 (ACTUAL)
- **Last updated:** 2023-12-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04564911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04564911, "GLucose Monitoring Programme SingaporE, Phase 2 (GLiMPSE2)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04564911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*